Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
Tara Hyder,1 Saveri Bhattacharya,2,* Kristine Gade,3,* Azadeh Nasrazadani,3 Adam M Brufsky3 1University of Pittsburgh Physicians, Pittsburgh, PA, USA; 2Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; 3UPMC Hillman Cancer Center, Magee...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f635ff8701c42129f91df04a69b4463 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5f635ff8701c42129f91df04a69b4463 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5f635ff8701c42129f91df04a69b44632021-12-02T15:59:22ZApproaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer1179-1314https://doaj.org/article/5f635ff8701c42129f91df04a69b44632021-03-01T00:00:00Zhttps://www.dovepress.com/approaching-neoadjuvant-therapy-in-the-management-of-early-stage-breas-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Tara Hyder,1 Saveri Bhattacharya,2,* Kristine Gade,3,* Azadeh Nasrazadani,3 Adam M Brufsky3 1University of Pittsburgh Physicians, Pittsburgh, PA, USA; 2Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; 3UPMC Hillman Cancer Center, Magee Women’s Hospital, Pittsburgh, PA, USA*These authors contributed equally to this workCorrespondence: Adam M BrufskyUPMC Hillman Cancer Center, Magee Women’s Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, 15213, USAEmail brufskyam@upmc.eduAbstract: Neoadjuvant therapy is integral to the treatment of early-stage breast cancer. Goals of treatment include surgical downstaging of the tumor, rendering inoperable tumors resectable, and de-escalating axillary surgery in those with clinically positive nodes. Additionally, response to treatment provides important prognostic information regarding risk of recurrence and guides future adjuvant treatment. Although chemotherapy serves as the backbone of neoadjuvant treatment, an increased understanding of the tumor’s clinical course as well as its molecular and genetic make-up aids in individualizing treatment and developing novel agents. This review summarizes current clinical approaches and the future direction to the management of breast cancer patients in the neoadjuvant setting.Keywords: neoadjuvant chemotherapy, neoadjuvant endocrine therapy, pCR, breast-conserving surgeryHyder TBhattacharya SGade KNasrazadani ABrufsky AMDove Medical Pressarticleneoadjuvant chemotherapyneoadjuvant endocrine therapypcrbreast conserving surgeryNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 13, Pp 199-211 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
neoadjuvant chemotherapy neoadjuvant endocrine therapy pcr breast conserving surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
neoadjuvant chemotherapy neoadjuvant endocrine therapy pcr breast conserving surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Hyder T Bhattacharya S Gade K Nasrazadani A Brufsky AM Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer |
description |
Tara Hyder,1 Saveri Bhattacharya,2,* Kristine Gade,3,* Azadeh Nasrazadani,3 Adam M Brufsky3 1University of Pittsburgh Physicians, Pittsburgh, PA, USA; 2Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; 3UPMC Hillman Cancer Center, Magee Women’s Hospital, Pittsburgh, PA, USA*These authors contributed equally to this workCorrespondence: Adam M BrufskyUPMC Hillman Cancer Center, Magee Women’s Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, 15213, USAEmail brufskyam@upmc.eduAbstract: Neoadjuvant therapy is integral to the treatment of early-stage breast cancer. Goals of treatment include surgical downstaging of the tumor, rendering inoperable tumors resectable, and de-escalating axillary surgery in those with clinically positive nodes. Additionally, response to treatment provides important prognostic information regarding risk of recurrence and guides future adjuvant treatment. Although chemotherapy serves as the backbone of neoadjuvant treatment, an increased understanding of the tumor’s clinical course as well as its molecular and genetic make-up aids in individualizing treatment and developing novel agents. This review summarizes current clinical approaches and the future direction to the management of breast cancer patients in the neoadjuvant setting.Keywords: neoadjuvant chemotherapy, neoadjuvant endocrine therapy, pCR, breast-conserving surgery |
format |
article |
author |
Hyder T Bhattacharya S Gade K Nasrazadani A Brufsky AM |
author_facet |
Hyder T Bhattacharya S Gade K Nasrazadani A Brufsky AM |
author_sort |
Hyder T |
title |
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer |
title_short |
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer |
title_full |
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer |
title_fullStr |
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer |
title_full_unstemmed |
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer |
title_sort |
approaching neoadjuvant therapy in the management of early-stage breast cancer |
publisher |
Dove Medical Press |
publishDate |
2021 |
url |
https://doaj.org/article/5f635ff8701c42129f91df04a69b4463 |
work_keys_str_mv |
AT hydert approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer AT bhattacharyas approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer AT gadek approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer AT nasrazadania approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer AT brufskyam approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer |
_version_ |
1718385331491831808 |